WVXU: How re-engineering HIV patient's blood may lead to a cure
Researchers at UC are collaborating in a study that will pinpoint and alter a specific gene in people with HIV. The hope is that process will lower the amount of HIV in the person’s body, and could possibly lead to the development of a cure for HIV.
WVXU interviewed Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine about the TRAILBLAZER study which will target and modify the C-C motif chemokine receptor (CCR5) gene, creating a mutation that prohibits the entry of HIV into specific white blood cells called lymphocytes.
Related Stories
UC Faculty Awards 2020: Alvaro Puga
April 22, 2020
Alvaro Puga is the winner of the 2020 George Rieveschl Award for Distinguished Scientific Research.
Cincinnati Enquirer: Behind the ventilator, specialists provide breaths for COVID-19 patients
April 21, 2020
Suzanne Bennett, MD, associate professor in the UC College of Medicine and UC Health anesthesiologist and critical care physician, spoke to the Cincinnati Enquirer for a story about ventilators, their operators and their roles in the COVID-19 pandemic. She said the respiratory therapists can be the lifesavers for some COVID-19 patients.